What We Do

ATPharma focuses on rapidly identifying and optimizing drug candidates that are more likely to succeed in clinical trials via combining quantum mechanics, molecular mechanics, thermodynamics, bioinformatics, and other computational tools with artificial intelligence and experiments in one platform. Our goals are:

• To improve existing treatments for several severe diseases such as cancer, diabetes, neurodegenerative, viral, and rare diseases.
• To gain quick ROI with natural pipeline and process development and custom synthesis using our automated platform.
• To discover novel targets and new drugs via a dual (natural, synthetic, and biological) confirmatory path.
• To decrease the cost of research and development by speeding up the process through our new platform and the know-how of our world-renowned team and receive protection under the patent umbrella for a more extended period.
• Drug repurposing of several challenging targets and diseases these unmet medical needs worldwide.
• Multitargeted drug development for combined treatment options.
• Unique food supplement and drug manufacturing portfolio to improve the well-being of human health.